Top

Published in:

01-12-2005 | Review Article

The application of immunohistochemistry in the diagnosis of bone tumors and tumor-like lesions

Authors: Zhenqiang Gao, Leonard B. Kahn

Published in: Skeletal Radiology | Issue 12/2005

Abstract

Immunohistochemistry (IHC) plays an important role in the diagnosis of some bone tumors, especially in the differential diagnosis of primary from metastatic non-osseous tumors and in the categorization of small-round-blue-cell tumors. This article reviews immunomarkers used in bone tumors and their diagnostic significance.

Coons AH. Labeled antigens and antibodies. Annu Rev Microbiol 1954;8:333–52CrossRefPubMed

Nakane PK, Pierce GB Jr. Enzyme-labeled antibodies for the light and electron microscopic localization of tissue antigens. J Cell Biol 1967;33 2:307–18CrossRefPubMed

Eckert F, de Viragh PA, Schmid U. Coexpression of cytokeratin and vimentin intermediate filaments in benign and malignant sweat gland tumors. J Cutan Pathol 1994;21 2:140–50PubMedCrossRef

Azumi N, Battifora H. The distribution of vimentin and keratin in epithelial and nonepithelial neoplasms. A comprehensive immunohistochemical study on formalin- and alcohol-fixed tumors. Am J Clin Pathol 1987;88 3:286–96PubMed

Miettinen M. Keratin subsets in spindle-cell sarcomas: keratins are widespread but synovial sarcoma contains a distinctive keratin polypeptide pattern and desmoplakins. Am J Pathol 1991;138:505–13PubMed

Kahn LB. Adamantinoma, osteofibrous dysplasia and differentiated adamantinoma. Skelet Radiol 2003;32 5:245–58CrossRef

O’Hara BJ, Paetau A, Miettinen M. Keratin subsets and monoclonal antibody HBME-1 in chordoma: immunohistochemical differential diagnosis between tumors simulating chordoma. Human Pathol 1998;29:119–26CrossRef

Gray MH, Rosenberg AE, Dickersin GR, Bhan AK. Cytokeratin expression in epithelioid vascular neoplasms. Human Pathol 1990;21 2:212–7CrossRef

O’Connell JX, Kattapuram SV, Mankin HJ, Bhan AK, Rosenberg AE. Epithelioid hemangioma of bone. A tumor often mistaken for low-grade angiosarcoma or malignant hemangioendothelioma. Am J Surg Pathol 1993;17 6:610–7PubMedCrossRef

10.

Aigner T, Frischholz S, Dertinger S. Type X collagen expression and hypertrophic differentiation in chondrogenic neoplasias. Histochem Cell Biol 1997;107:435–40CrossRefPubMed

11.

Granter SR, Renshaw AA, Fletcher CD. CD99 reactivity in mesenchymal chondrosarcoma. Human Pathol 1996;27:1273–6CrossRefPubMed

12.

Folpe AL, Schmidt RA, Chapman D, Gown AM. Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors. Am J Surg Pathol 1998;22 6:673–82CrossRefPubMed

13.

Theaker JM, Gatter KC, Esiri MM Fleming KA. Epithelial membrane antigen and cytokeratin expression by meningiomas: an immunohistological study. J Clin Pathol 1986;39 4:435–9PubMedCrossRef

14.

Swanson C, Perentes E, Phillips L. Epithelial membrane antigen reactivity in mesenchymal neoplasms: an immunohistochemical study of 306 soft tissue sarcomas. Surg Pathol 1992;2:313–22

15.

Park HR, Park YK, Jang KT, Unni KK. Expression of collagen type II, S100B, S100A2 and osteocalcin in chondroblastoma and chondromyxoid fibroma. Oncol Rep 2002;9:1087–91PubMed

16.

Nakajima T, Kameya T, Watanabe S. S-100 protein distribution in normal and neoplastic tissues. In: DeLellis R, editor. Advances in immunohistochemistry. New York: Mason; 1984. pp. 141–58

17.

Bleiweiss IJ, Klein MJ. Chondromyxoid fibroma: report of six cases with immunohistochemical studies. Mod Pathol 1990;3:664–6PubMed

18.

Monda L, Wick MR. S-100 protein immunostaining in the differential diagnosis of chondroblastoma. Human Pathol 1985;16:287–293CrossRef

19.

Gebhard S, Coindre JM, Michels JJ, Terrier P, Bertrand G, Trassard M, Taylor S, Chateau MC, Marques B, Picot V, Guillou L. Pleomorphic liposarcoma. Clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases: a study from the French Federation of Cancer Centers Sarcoma Group. Am J Surg Pathol 2002;26 5:601–16CrossRefPubMed

20.

Folpe AL, Weiss SW. Ossifying fibromyxoid tumor of soft parts: a clinicopathologic study of 70 cases with emphasis on atypical and malignant variants. Am J Surg Pathol 2003;27 4:421–31CrossRefPubMed

21.

Rosenberg AE, Nielsen GP, Keel SB, Renard LG, Fitzek MM, Munzenrider JE, Liebsch NJ. Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. Am J Surg Pathol 1999;23 11:1370–8CrossRefPubMed

22.

Pinkus GS, Lones MA, Matsumura F, Yamashiro S, Said JW, Pinkus JL. Langerhans cell histiocytosis immunohistochemical expression of fascin, a dendritic cell marker. Am J Clin Pathol 2002;118 3:335–43CrossRefPubMed

23.

Arber DA, Weiss LM. CD57: a review. Appl Immunohistochem 1995;3:137–52

24.

Gould VE, Lee I, Wiedenmann B. Synaptophysin: a novel marker for neurons, certain neuroendocrine cells, and their neoplasms. Human Pathol 1986;17:979–83CrossRef

25.

De Young BR, Frierson HF Jr, Ly MN, Smith D, Swanson PE. CD31 immunoreactivity in carcinomas and mesotheliomas. Am J Clin Pathol 1998;110:374–7PubMed

26.

Miettinen M, Lindenmayer AE, Chaubal A. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens—evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 1994;7 1:82–90PubMed

27.

Fanburg-Smith JC, Miettinen M. Angiomatoid “malignant” fibrous histiocytoma: a clinicopathologic study of 158 cases and further exploration of the myoid phenotype. Human Pathol 1999;30 11:1336–43CrossRef

28.

Lessard JL. Two monoclonal antibodies to actin: one muscle selective and one generally reactive. Cell Motil Cytoskelet 1988;10 3:349–62CrossRef

29.

Sebire NJ, Malone M. Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas. J Clin Pathol 2003;56 6:412–6CrossRefPubMed

30.

Llombart-Bosch A, Navarro S. Immunohistochemical detection of EWS and FLI-1 proteins in Ewing sarcoma and primitive neuroectodermal tumors: comparative analysis with CD99 (MIC-2) expression. Appl Immunohistochem Mol Morphol 2001;9 3:255–60CrossRefPubMed

31.

Amann G, Zoubek A, Salzer-Kuntschik M, Windhager R, Kovar H. Relation of neurological marker expression and EWS gene fusion types in MIC2/CD99-positive tumors of the Ewing family. Human Pathol 1999;30 9:1058–64CrossRef

32.

Garin-Chesa P, Fellinger EJ, Huvos AG, Beresford HR, Melamed MR, Triche TJ, Rettig WJ. Immunohistochemical analysis of neural cell adhesion molecules. Differential expression in small round cell tumors of childhood and adolescence. Am J Pathol 1991;139 2:275–86PubMed

33.

Miettinen M, Cupo W. Neural cell adhesion molecule distribution in soft tissue tumors. Human Pathol 1993;24 1:62–6CrossRef

34.

Folpe AL, Hill CE, Parham DM, O’Shea PA, Weiss SW. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor. Am J Surg Pathol 2000;24 12:1657–62PubMedCrossRef

35.

Bacchi CE, Bonetti F, Pea M. HMB-45, a review. Appl Immunohistochem 1996;4:73–80

36.

Gao ZQ, Bhuiya T, Anderson A. Perivascular epithelioid cell tumor (PEComa) of the uterus associated with malignant neoplasm of the female genital tract: a case report and literature review. J Obstet Gynaecol 2004;5:600–4CrossRef

37.

Fanburg-Smith JC, Bratthauer GL, Miettinen M. Osteocalcin and osteonectin immunoreactivity in extraskeletal osteosarcoma: a study of 28 cases. Human Pathol 1999;30 1:32–8CrossRef

38.

Fanburg JC, Rosenberg AE, Weaver DL. Osteocalcin and osteonectin immunoreactivity in the diagnosis of osteosarcoma. Am J Clin Pathol 1997;108 4:464–73PubMed

39.

Serra M, Morini MC, Scotlandi K, Fisher LW, Zini N, Colombo MP, Campanacci M, Maraldi NM, Olivari S, Baldini N. Evaluation of osteonectin as a diagnostic marker of osteogenic bone tumors. Human Pathol 1992;23 12:1326–31CrossRef

40.

Hall PA, Richards MA, Gregory WM, d'Ardenne AJ, Lister TA, Stansfeld AG. The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. J Pathol 1988;154 3:223–35CrossRefPubMed

41.

Ueda T, Aozasa K, Tsujimoto M, Ohsawa M, Uchida A, Aoki Y, Ono K, Matsumoto K. Prognostic significance of Ki-67 reactivity in soft tissue sarcomas. Cancer 1989;63 8:1607–11PubMedCrossRef

42.

Okamoto S, Hisaoka M, Ishida T, Imamura T, Kanda H, Shimajiri S, Hashimoto H. Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 18 cases. Human Pathol 2001;32 10:1116–24CrossRef

43.

Edel G, Ueda Y, Nakanishi J, Brinker KH, Roessner A, Blasius S, Vestring T, Muller-Miny H, Erlemann R, Wuisman P. Chondroblastoma of bone. A clinical, radiological, light and immunohistochemical study. Virchows Arch 1992;421 4:355–66CrossRef

44.

Masui F, Ushigome S, Fujii K. Giant cell tumor of bone: an immunohistochemical comparative study. Pathol Int 1998;48 5:355–61PubMedCrossRef

45.

Nielsen GP, Keel SB, Dickersin GR, Selig MK, Bhan AK, Rosenberg AE. Chondromyxoid fibroma: a tumor showing myofibroblastic, myochondroblastic, and chondrocytic differentiation. Mod Pathol 1999;12 5:514–7PubMed

46.

Almeida J, Orfao A, Mateo G, Ocqueteau M, Garcia-Sanz R, Moro MJ, Hernandez J, Ortega F, Borrego D, Barez A, Mejido M, San Miguel JF. Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance. Pathol Biol (Paris) 1999;47 2:119–27

47.

Tworek JA, Singleton TP, Schnitzer B, Hsi ED, Ross CW. Flow cytometric and immunohistochemical analysis of small lymphocytic lymphoma, mantle cell lymphoma, and plasmacytoid small lymphocytic lymphoma. Am J Clin Pathol 1998;110 5:582–9PubMed

48.

Heyning FH, Hogendoorn PC, Kramer MH, Hermans J, Kluin-Nelemans JC, Noordijk EM, Kluin PM. Primary non-Hodgkin's lymphoma of bone: a clinicopathological investigation of 60 cases. Leukemia 1999;13 12:2094–8CrossRefPubMed

49.

Lopez P, Estes ML. Immunophenotypic characterization of sinus histiocytosis with massive lymphadenopathy: analysis of an extranodal case. Human Pathol 1989;20:711–5CrossRef

50.

Myers JL, Bernreuter W, Dunham W. Melanotic schwannoma. Clinicopathologic, immunohistochemical, and ultrastructural features of a rare primary bone tumor. Am J Clin Pathol 1990;93 3:424–9PubMed

51.

Karabela-Bouropoulou V, Markaki S, Prevedorou D, Vidali N. A combined immunohistochemical and histochemical approach on the differential diagnosis of giant cell epiphyseal neoplasms. Pathol Res Pract 1989;184 2:184–7PubMed

52.

Panico L, Passeretti U, De Rosa N. Giant cell reparative granuloma of the distal skeletal bones: a report of five cases with immunohistochemical findings. Virchows Arch 1994;425:315–20CrossRefPubMed

53.

Maruno M, Yoshimine T, Kubo T. A case of giant cell reparative granuloma of the petrous bone: demonstration of the proliferative component. Surg Neurol 1997;48:64–8CrossRefPubMed

54.

Juliao SF, Rand N, Schwartz HS. Galectin-3: a biologic marker and diagnostic aid for chordoma. Clin Orthop 2002;397:70–5PubMedCrossRef

55.

Hall PA, O’Doherty CJ, Levison DA. Langerhan's cell histiocytosis: an unusual case illustrating the value of immunohistochemistry in diagnosis. Histopathology 1988;12 4:458PubMedCrossRef

56.

Pileri SA, Grogan TM, Harris NL, Banks P, Campo E, Chan JK, Favera RD, Delsol G, De Wolf-Peeters C, Falini B, Gascoyne RD, Gaulard P, Gatter KC, Isaacson PG, Jaffe ES, Kluin P, Knowles DM, Mason DY, Mori S, Muller-Hermelink HK, Piris MA, Ralfkiaer E, Stein H, Su IJ, Warnke RA, Weiss LM. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 2002;41:1–29CrossRefPubMed

57.

Dillon KM, Hill CM, Cameron CH, Attanoos RL, McCluggage WG. Mediastinal mixed dendritic cell sarcoma with hybrid features. J Clin Pathol 2002;55:791–4CrossRefPubMed

58.

World Health Organization. Classification of tumors. Tumors of the hematopoietic and lymphoid tissues. IARC Press; 2001

59.

Hanson CA, Jaszcz W, Kersey JH, Astorga MG, Peterson BA, Gajl-Peczalska KJ, Frizzera G. True histiocytic lymphoma: histopathologic, immunophenotypic and genotypic analysis. Br J Haematol 1989;73 2:187–98PubMed

60.

Egan AJ, Boardman LA, Tazelaar HD, Swensen SJ, Jett JR, Yousem SA, Myers JL. Erdheim–Chester disease: clinical, radiologic, and histopathologic findings in five patients with interstitial lung disease. Am J Surg Pathol 1999;23 1:17–26CrossRefPubMed

61.

World Health Organization. Classification of tumors. Tumors of the soft tissue and bone. IARC Press; 2002

62.

Eisen RN, Buckley PJ, Rosai J. Immunophenotypic characterization of sinus histiocytosis with massive lymphadenopathy (Rosai–Dorfman disease). Semin Diagn Pathol 1990;7 1:74–82PubMed

63.

Tzankov A, Zimpfer A, Pehrs AC, Lugli A, Went P, Maurer R, Pileri S, Dirnhofer S. Expression of B-cell markers in classical Hodgkin lymphoma: a tissue microarray analysis of 330 cases. Mod Pathol 2003;16 11:1141–7CrossRefPubMed

64.

O’Neill MC, Song L. Neural network analysis of lymphoma microarray data: prognosis and diagnosis near-perfect. BMC Bioinformatics 2003;4 1:13CrossRefPubMed

65.

Li S, Ross DT, Kadin ME, Brown PO, Wasik MA. Comparative genome-scale analysis of gene expression profiles in T cell lymphoma cells during malignant progression using a complementary DNA microarray. Am J Pathol 2001;158 4:1231–7PubMed

Title: The application of immunohistochemistry in the diagnosis of bone tumors and tumor-like lesions
Authors: Zhenqiang Gao
Leonard B. Kahn
Publication date: 01-12-2005
Publisher: Springer-Verlag
Published in: Skeletal Radiology / Issue 12/2005
Print ISSN: 0364-2348
Electronic ISSN: 1432-2161
DOI: https://doi.org/10.1007/s00256-005-0001-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The application of immunohistochemistry in the diagnosis of bone tumors and tumor-like lesions

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2005

Transarticular invasion of bone tumours across the sacroiliac joint

Radicular pain after vertebroplasty: complication and prevention

Osteochondritis dissecans after rotational acetabular osteotomy for dysplastic hip

Extraskeletal mesenchymal chondrosarcoma: an imaging review of ten new patients

Tophaceous gout in the cervical spine

Degeneration in dysplastic hips